41988-26-5

Basic information

• Product Name: 7-(2-bromoethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
• Synonyms: 7-(2-bromoethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one
• CAS NO: 41988-26-5
• Molecular Weight: 361.192
• Mol File: 41988-26-5.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: 7-(2-bromoethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7-(2-bromoethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one(41988-26-5)
• EPA Substance Registry System: 7-(2-bromoethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one(41988-26-5)

Safety Data

• Hazardous Substances Data: 41988-26-5(Hazardous Substances Data)

Upstream product

• 33507-94-7 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenylpropane-1,3-dione 
• 33495-30-6 2-benzoyloxy-4,6-dimethoxyacetophenone 
• 90-24-4 2-hydroxy-4,6-dimethoxyacetophenone 
• 480-40-0 5,7-dihydroxy-2-phenyl-chromen-4-one 
• 106-93-4 ethylene dibromide 

Downstream Products

• 1141487-91-3 O₇-nitrooxyethyl chrysin 
• 1236122-45-4 7-(2-morpholinoethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-58-9 7-(2-(1H-imidazol-1-yl)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-61-4 7-(2-(2-methyl-1H-imidazol-1-yl)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-53-4 7-(2-(4-benzylpiperazin-1-yl)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-81-8 7-(2-(cyclohexylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-64-7 7-(2-(2'-hydroxyethylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-77-2 7-(2-(isopropylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-79-4 7-(2-(tert-butylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-78-3 7-(2-(butylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-80-7 7-(2-(diisopropylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1236122-76-1 7-(2-(methylamino)ethoxy)-5-hydroxy-2-phenyl-4H-chromen-4-one 
• 1517965-09-1 chrysin-ethylidene-norfloxacin 
• 1517965-24-0 chrysin-ethylidene-sarafloxacin 

Relevant articles and documents

Synthesis and preliminary biological evaluation for the anticancer activity of organochalcogen (S/se) tethered chrysin-based organometallic RuII(η6-p-cymene) complexes

Organochalcogen (S/Se) functionalized chrysin derivatives were synthesized and coordinated with RuII(η6-p-cymene) to efficiently form ruthenium-based chemotherapeutic drug entities [C31H35O4SRuCl]; [C

Synthesis and evaluation of antitumour activity in vitro and in vivo of chrysin salicylate derivatives

A series of chrysin salicylate derivatives as potential antitumour agents were synthesised and evaluated their antitumour activities in vitro and in vivo. Most of the compounds exhibited moderate to good activities against MCF-7 cells, HepG2 cells, MGC-80

Synthesis of flavonoids nitrogen mustard derivatives and study on their antitumor activity in vitro

Several novel flavonoids nitrogen mustard derivatives were synthesized and evaluated for antiproliferative activity against seven human cancer cell lines (HeLa, A549, HepG2, MCF7, SH-SY5Y, PC-3, DU145) by the MTT assay in vitro. The resulting IC50/s

Novel photosensitizing properties of porphyrin–chrysin derivatives with antitumor activity in vitro

Photodynamic therapy is a promising cancer treatment with the advantages of low toxicity, high efficiency, and noninvasiveness. In this study, 23 novel porphyrin–chrysin derivatives are synthesized using alkyl carbon chains as bridges. We use human gastri